ReviewPharmacology research & perspectives2024

Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitors.

Jennifer H Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.